Pediatric electrolyte solution, also known as oral rehydration solution, is used to manage excessive body water due to diarrhea and vomiting. The solution comprises salt, water, and sugar, which replace fluids and electrolytes that are lost from the body. It also helps the intestines absorb water to prevent further dehydration. Moreover, increasing worldwide cases of diarrhea is expected to boost the market growth. For instance, according to an article published by the Global Burden of Disease in November 2019, diarrheal disease was the cause of every 10 children’s death in 2017 and more than half a million of the 5.4 million children that died in 2017 died due to diarrheal disease.
The global pediatric electrolyte solution market is estimated to be valued at US$ 987.7 million in 2020 and is expected to exhibit a CAGR of 6.2% during the forecast period (2020-2027).
Figure 1. Global Pediatric Electrolyte Solution Market Share (%), by Region, 2020
Rising diarrheal cases in infants and children is expected to propel growth of the global pediatric electrolyte solution market
Rising diarrheal cases worldwide, especially in under developed countries is expected to boost the market growth over the forecast period. For instance, according to an article published by the Institute for Health Metrics and Evaluation (IHME) in September 2018, there was an estimated 30 million cases of severe diarrhea and 330,000 deaths of children younger than 5 years of age in Africa in 2015.
Pediatric Electrolyte Solution Market Report Coverage
|Base Year:||2019||Market Size in 2020:||US$ 987.7 Mn|
|Historical Data for:||2016 to 2019||Forecast Period:||2020 to 2027|
|Forecast Period 2020 to 2027 CAGR:||6.2%||2027 Value Projection:||US$ 1,504.8 Mn|
Mead Johnson, Abbott, Johnson and Johnson Services Inc., Otsuka Pharmaceutical Co., Ltd., Pendopharma, McKesson Medical-Surgical Inc., Good Sense (Perrigo Company plc), KINDERLYTE, Suero Oral Inc., and SOS Hydration
|Restraints & Challenges:||
Figure 2. Global Pediatric Electrolyte Solution Market Share (%), by Type, 2020
Product launches in North America is expected to boost the market growth
North America is expected to hold dominant position in the global pediatric electrolyte solution market, owing to increasing product launches in this region. For instance, in April 2016, Pace Wellness, an innovator and manufacturer that uses an advanced, patented drug-delivery platform to make oral dissolvable pharmaceutical and nutraceutical products, launched Solves strips, a pediatric electrolyte oral thin-film, a disruptive innovation for medicine delivery. These pediatric electrolyte strips are formulated with a controlled dosage of essential electrolytes for children of 2 years and older to quickly replenish electrolytes and helps to gain fluid retention.
Global Pediatric Electrolyte Solution Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses in all sectors. The private healthcare is one such sector which has been impacted significantly by the COVID-19 pandemic.
The lockdown in various countries due to the pandemic has placed an economic burden on the healthcare sector. Moreover, the coronavirus pandemic has hampered the development, production, and supply of drugs and other healthcare products and affected growth of healthcare businesses of various companies across the globe.
As a result, the impact of the COVID-19 pandemic is expected to limit growth of the global pediatric electrolyte solution market during the forecast period.
Major players operating in the global pediatric electrolyte solution market include Mead Johnson, Abbott, Johnson and Johnson Services Inc., Otsuka Pharmaceutical Co., Ltd., Pendopharma, McKesson Medical-Surgical Inc., Good Sense (Perrigo Company plc), KINDERLYTE, Suero Oral Inc., and SOS Hydration.
Frequently Asked Questions